RA0464

antibody from Oursmab

Targeting: LILRA4 CD85g, ILT7

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0464

Provider

Oursmab

Product name

Daxdilimab (Biosimilar Reference Antibody) (LILRA4)

Antibody type

Monoclonal

Description

Daxdilimab is an investigational monoclonal antibody targeting the Leukocyte Immunoglobulin-Like Receptor subfamily A member 4 (LILRA4, also known as ILT7). This receptor is specifically and highly expressed on plasmacytoid dendritic cells (pDCs). By modulating the ILT7 signaling pathway, daxdilimab aims to regulate pDC function and, consequently, the broader immune response. This mechanism positions it as a potential therapeutic for autoimmune or inflammatory diseases where pDCs and type I interferon pathways are dysregulated.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Daxdilimab (Biosimilar Reference Antibody) (LILRA4)-RA0464-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Daxdilimab (Biosimilar Reference Antibody) (LILRA4)-RA0464 in a linear range of 0.18-125 ng/mL.